HRTX(HRTX)
HRTX
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $168M | $176M | $202M | $240M | $269M |
| Low | $161M | $168M | $202M | $230M | $258M |
| High | $175M | $183M | $202M | $250M | $280M |
| EBITDA Avg | $-100M | $-104M | $-120M | $-142M | $-160M |
| Low | $-104M | $-109M | $-120M | $-148M | $-166M |
| High | $-96M | $-100M | $-120M | $-136M | $-153M |
| EBIT Avg | $-102M | $-106M | $-122M | $-145M | $-163M |
| Low | $-106M | $-111M | $-122M | $-151M | $-169M |
| High | $-97M | $-102M | $-122M | $-139M | $-156M |
| Net Income Avg | $-9M | $-2M | $17M | $29M | $41M |
| Low | $-9M | $-2M | $10M | $28M | $39M |
| High | $-8M | $-2M | $20M | $31M | $43M |
| EPS Avg | $-0.05 | $-0.01 | $0.09 | $0.17 | $0.24 |
| Low | $-0.06 | $-0.01 | $0.06 | $0.17 | $0.23 |
| High | $-0.05 | $-0.01 | $0.12 | $0.18 | $0.26 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 2 / 2 | 1 / 1 | 1 / 1 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 |
|---|---|---|---|
| Revenue Avg | $42M | $43M | $47M |
| Low | $42M | $42M | $46M |
| High | $42M | $44M | $49M |
| EBITDA Avg | $-25M | $-26M | $-28M |
| Low | $-25M | $-26M | $-29M |
| High | $-25M | $-25M | $-27M |
| EBIT Avg | $-25M | $-26M | $-29M |
| Low | $-26M | $-27M | $-30M |
| High | $-25M | $-25M | $-28M |
| Net Income Avg | $-1M | $-1M | $-632,090 |
| Low | $-1M | $-1M | $-655,748 |
| High | $-1M | $-1M | $-608,219 |
| EPS Avg | $-0.01 | $-0.01 | $-0.00 |
| Low | $-0.01 | $-0.01 | $-0.00 |
| High | $-0.01 | $-0.01 | $-0.00 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 |